Envoy Medical, Inc. (COCH)
Nasdaq · Healthcare · Medical Devices
$0.651−2.40%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $50.3M
- 52-week range
- $0.363 – $1.89
- 52-week change
- −57.36%
- EPS (trailing)
- −$0.76
Fiscal year to Dec 2025
- Revenue
- $241K (+7.11%)
- Net income
- −$23.8M
- Operating margin
- −9240.7%
- Diluted EPS
- −$1.23
- Free cash flow
- −$18.4M
From the company’s annual report on SEC EDGAR.
About Envoy Medical, Inc.
Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Headquarters: White Bear Lake, United States · 43 employees · envoymedical.com